News from the FDA/CDC

Children and COVID: A look back as the fourth year begins


 

Since Omicron

There has not been another major COVID-19 surge since the winter of 2021-2022, when the weekly rate of new cases reached 1,900 per 100,000 population in children aged 16-17 years in early January 2022 – the highest seen among children of any of the CDC’s age groups (0-4, 5-11, 12-15, 16-17) during the entire pandemic. Since the Omicron surge, the highest weekly rate was 221 per 100,000 during the week of May 15-21, again in 16- to 17-year-olds, the CDC reports.

The widely anticipated surge of COVID in the fall and winter of 2022 and 2023 – the so-called “tripledemic” involving influenza and respiratory syncytial virus – did not occur, possibly because so many Americans were vaccinated or previously infected, experts suggested. New-case rates, emergency room visits, and hospitalizations in children have continued to drop as winter comes to a close, CDC data show.

Pages

Recommended Reading

New challenge for docs: End of COVID federal public health emergency
Federal Practitioner
Cardiac issues twice as likely with COVID plus high troponin
Federal Practitioner
What’s new in brain health?
Federal Practitioner
COVID infection provides immunity equal to vaccination: Study
Federal Practitioner
COVID vs. flu: Which is deadlier?
Federal Practitioner
Prone positioning curbs need for intubation in nonintubated COVID-19 patients
Federal Practitioner
Even mild COVID is hard on the brain
Federal Practitioner
One in four parents lied about kids’ COVID status: Survey
Federal Practitioner
‘Breakthrough’ study: Diabetes drug helps prevent long COVID
Federal Practitioner
Factors linked with increased VTE risk in COVID outpatients
Federal Practitioner